PRESS RELEASE published on 06/17/2025 at 07:55, 1 year ago EQS-Adhoc: Formycon plans to issue a public senior unsecured floating rate bond with target volume of EUR 50 million to support further company growth Formycon AG plans EUR 50 million senior unsecured bond issuance for company growth. Joint Lead Managers: IKB Deutsche Industriebank AG, Pareto Securities AS Formycon AG Bond Issuance EUR 50 Million Senior Unsecured Joint Lead Managers
PRESS RELEASE published on 06/17/2025 at 07:35, 1 year ago AFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production AFYREN begins new phase of industrial strategy with continuous production at first plant AFYREN NEOXY, accelerating commercialization and securing €165 million in revenue contracts AFYREN Continuous Production Bio-based Acids Industrial Strategy Revenue Contracts
PRESS RELEASE published on 06/17/2025 at 07:33, 1 year ago PIERER Mobility AG: Restructuring plans for KTM AG, KTM Components GmbH, and KTM Forschungs & Entwicklungs GmbH are legally binding PIERER Mobility AG successfully completes restructuring plans for KTM AG, KTM Components GmbH, and KTM Forschungs & Entwicklungs GmbH, transferring 30% of recognized claims to creditors PIERER Mobility AG Restructuring Plans KTM AG KTM Components GmbH KTM Forschungs & Entwicklungs GmbH
PRESS RELEASE published on 06/17/2025 at 07:30, 1 year ago Solid half-year results for 2024-2025 and confirmation of the potential of growth drivers Vente-unique.com reports 12.6% increase in gross merchandise volume, revenue up 8.4%. Adjusted Ebitda at 11.4%. Q3 sales expected to accelerate. Strong growth ambitions. New warehouse and expansion plans Financial Results Profitable Growth Online Sales Market Expansion Vente-unique.com
PRESS RELEASE published on 06/17/2025 at 07:30, 1 year ago Inside Information / Other news releases AFYREN announces the successful continuous production achievement at AFYREN NEOXY plant, marking a new industrial strategy phase. Hundreds of tons of bio-based acids produced & commercialized. Short-term revenue & objective updates revealed Revenue Objectives AFYREN Continuous Production Bio-based Acids Industrial Strategy
PRESS RELEASE published on 06/17/2025 at 07:01, 1 year ago Press release: Leonteq becomes exclusive market maker for ETPs on BX Swiss as it strengthens its retail strategy Leonteq becomes exclusive market maker for ETPs on BX Swiss, strengthening retail strategy. Expanded product range includes listed leverage products for retail investors Leonteq BX Swiss Market Maker Retail Strategy ETPs
PRESS RELEASE published on 06/17/2025 at 07:00, 1 year ago BX Swiss and Leonteq are strengthening their partnership by offering exclusive market making for ETPs BX Swiss and Leonteq strengthen partnership with exclusive market making for ETPs, enhancing liquidity and market quality on BX Swiss Partnership Leonteq BX Swiss Market Making ETPs
PRESS RELEASE published on 06/17/2025 at 07:00, 1 year ago Inside Information / Other news releases Innate Pharma to participate in H.C. Wainwright and Wolfe Research healthcare conferences showcasing their innovative immunotherapy approaches. Global biotech company expanding portfolio Biotechnology Immunotherapy Clinical-stage Innate Pharma Healthcare Conferences
PRESS RELEASE published on 06/17/2025 at 01:07, 1 year ago Askeladden Town Hall Spotlights Clear Choice for AstroNova: Hands-On Reform or Hands-Off Failure Askeladden shares replay of town hall showcasing nominees' relevant experience. AstroNova's incentives face criticism. Alexis Michas finds scheduling call 'complicated'. 1,000+ aerospace transactions highlight strategic opportunities. Shareholders urged to vote for Askeladden nominees for change at AstroNova Shareholders Strategic Alternatives Town Hall AstroNova Askeladden
PRESS RELEASE published on 06/17/2025 at 00:45, 1 year ago New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST New to The Street announces Show #672 featuring FLOKI, BioVie Inc., NRX Pharmaceuticals, and Vita Bella on Fox Business Network. Interviews with innovative companies shaping markets Innovation BioVie Inc. Floki NRx Pharmaceuticals Vita Bella
Published on 06/20/2026 at 01:00, 18 hours 49 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 19 hours 49 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 15 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 18 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 18 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 06:00, 13 hours 49 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 23 hours 32 minutes ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 1 hour ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 2 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 2 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026